Cancer is the leading cause of death in dogs over the age of two and represents a significant unmet medical need in veterinary medicine, with an estimated 6 million dogs diagnosed with cancer each year. ELIAS Cancer Immunotherapy has received full approval from the U.S. Department of Agriculture Center for Veterinary Biologics as the first autologous prescription product to receive indicated for the treatment of canine osteosarcoma, a deadly form of bone cancer.
Source: ELIAS Animal Health, March 19, 2025. Link.
Leave a Reply